Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: A post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial

The Lancet Neurology

Volumn 11, Issue 6, 2012, Pages 512-520

  Hankey, Graeme J ^a   Eikelboom, John W ^b   Yi, Qilong ^c   Lees, Kennedy R ^d   Chen, Christopher ^e   Xavier, Denis ^f   Navarro, Jose C ^g   Ranawaka, Udaya K ^h   Uddin, Wasim ⁱ   Ricci, Stefano ^j   Gommans, John ^k   Schmidt, Reinhold ^l  

^a ROYAL PERTH HOSPITAL   (Australia)

^b MCMASTER UNIVERSITY   (Canada)

^c CANADIAN BLOOD SERVICES   (Canada)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^g Jose R Reyes Memorial Medical Center   (Philippines)

^h UNIVERSITY OF KELANIYA   (Sri Lanka)

ⁱ POF Hospital   (Pakistan)

^j Azienda Sanitaria Locale 1 dell'Umbria ^*  (Italy)

^k HAWKE S BAY HOSPITAL   (New Zealand)

^l MEDICAL UNIVERSITY OF GRAZ   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE; ANTITHROMBOCYTIC AGENT; PLACEBO;

ADULT; AGE DISTRIBUTION; ANTICOAGULANT THERAPY; ARTICLE; ASIAN; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAUSE OF DEATH; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; STROKE; TRANSIENT ISCHEMIC ATTACK; VITAMIN SUPPLEMENTATION; AGED; ATRIAL FIBRILLATION; CARDIOEMBOLIC STROKE; CEREBROVASCULAR ACCIDENT; DISABLED PERSON; EAST ASIAN; POST HOC ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

AGED; DOUBLE-BLIND METHOD; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; TREATMENT OUTCOME; VITAMIN B 12; VITAMIN B 6; VITAMIN B COMPLEX;

EID: 84861191434     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(12)70091-1     Document Type: Article

References (15)

1. Wald DS, Wald NJ, Morris JK, Law M Folic acid, homocysteine and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ 2006, 333:114-117.
2. Faraci FM, Lentz SR Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke 2004, 35:345-347.
3. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 2005, 82:806-812. Homocysteine Lowering Trialists' Collaboration.
4. Clarke R, Halsey J, Lewington S, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med 2010, 170:1622-1631.
5. Spence JD, Stampfer MJ Understanding the complexity of homocysteine lowering with vitamins: the potential role of subgroup analyses. JAMA 2011, 306:2610-2611.
6. Holmes MV, Newcombe P, Hubacek JA, et al. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet 2011, 378:584-594.
7. Wald DS, Morris JK, Wald NJ Reconciling the evidence on serum homocysteine and ischaemic heart disease: a meta-analysis. PLoS One 2011, 6:e16473.
8. Wang X, Qin X, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 2007, 369:1876-1882.
9. Saposnik G, Ray JG, Sheridan P, McQueen M, Lonn E Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial. Stroke 2009, 40:1365-1372.
10. Patrono C, García Rodríguez LA, Landolfi R, Baigent C Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005, 353:2373-2383.
11. Hankey GJ, Eikelboom JW Homocysteine and vascular disease. Lancet 1999, 354:407-413.
12. Kaul S, Zadeh AA, Shah PK Homocysteine hypothesis for atherothrombotic cardiovascular disease not validated. J Am Coll Cardiol 2006, 48:914-923.
13. Ungvari Z, Sarkadi-Nagy E, Bagi Z, Szollar L, Koller A Simultaneously increased TxA(2) activity in isolated arterioles and platelets of rats with hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 2000, 20:1203-1208.
14. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol 2010, 9:855-865. VITATOPS Trial Study Group.
15. Rothwell PM Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 2005, 365:176-186.